<DOC>
	<DOC>NCT02769858</DOC>
	<brief_summary>The proposed study aims to establish the feasibility of light therapy for postpartum depression delivered via Re-Timer, demonstrate its preliminary efficacy, and illuminate relationships between circadian shifts and mood changes using a novel, home-based circadian biomarker assessment paradigm (salivary dim light melatonin onset; DLMO).</brief_summary>
	<brief_title>The Effects of Light Therapy on Circadian Rhythms, Sleep, and Mood in Postpartum Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression, Postpartum</mesh_term>
	<criteria>Within 6 months postpartum Meet DSMV diagnostic criteria for MDD Score â‰¥ 20 on the Structured Interview Guide for the Hamilton Depression Rating ScaleSeasonal Affective Disorder version (SIGHSAD). current diagnosis of bipolar disorder, posttraumatic stress disorder, schizophrenia or psychosis, dissociative disorders, eating disorder, obsessivecompulsive disorder, somatic symptom and related disorders, substance use disorder, panic disorder, agoraphobia per DSMV past history of mania/hypomania, chronic medical conditions associated with depression (e.g., thyroid conditions) ocular or retinal pathology history of seizures or epilepsy color blindness Lupus currently taking an antibiotic, medication that contains hydrochlorothiazide, or isotretinoin (Accutane).</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>